Trial
NCT00816413
Donor Stem Cell Transplant, Pentostatin, and Total-Body Irradiation in Treating Patients With Hematological Cancer
Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Nebraska
Collaborators
National Cancer Institute (NCI)
Condition
Chronic Myeloproliferative Disorders
Intervention
cyclosporine
Why stopped
Screenings yielded inadequate eligible subjects to enroll.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-08-14